198 related articles for article (PubMed ID: 33369471)
1. Influence of a 5-bp Indel Polymorphism at Promoter of the GAS5 lncRNA and Risk of Breast Cancer.
Sharifi R; Shahangian SS; Salehi Z; Mashayekhi F; Talesh Sasani S; Mirzanezhad L
Asian Pac J Cancer Prev; 2020 Dec; 21(12):3705-3710. PubMed ID: 33369471
[TBL] [Abstract][Full Text] [Related]
2. A Genetic Variant of rs145204276 in the Promoter Region of Long Noncoding RNA GAS5 Is Associated With a Reduced Risk of Breast Cancer.
Tang Y; Wang Y; Wang X; Liu Y; Zheng K
Clin Breast Cancer; 2019 Jun; 19(3):e415-e421. PubMed ID: 30846409
[TBL] [Abstract][Full Text] [Related]
3. A Functional Polymorphism rs145204276 in the Promoter of Long Noncoding RNA GAS5 Is Associated with an Increased Risk of Ischemic Stroke.
Zheng Z; Liu S; Wang C; Han X
J Stroke Cerebrovasc Dis; 2018 Dec; 27(12):3535-3541. PubMed ID: 30197169
[TBL] [Abstract][Full Text] [Related]
4. LncRNA GAS5 Indel Genetic Polymorphism Contributes to Glioma Risk Through Interfering Binding of Transcriptional Factor TFAP2A.
Yuan J; Zhang N; Zheng Y; Chen YD; Liu J; Yang M
DNA Cell Biol; 2018 Sep; 37(9):750-757. PubMed ID: 30074406
[TBL] [Abstract][Full Text] [Related]
5. Association Between the Deletion Allele of Ins/Del Polymorphism (Rs145204276) in the Promoter Region of GAS5 with the Risk of Atherosclerosis.
Shen Z; She Q
Cell Physiol Biochem; 2018; 49(4):1431-1443. PubMed ID: 30205366
[TBL] [Abstract][Full Text] [Related]
6. The functional 4-bp insertion/deletion ATTG polymorphism in the promoter region of NF-KB1 reduces the risk of BC.
Eskandari-Nasab E; Hashemi M; Ebrahimi M; Amininia S
Cancer Biomark; 2016; 16(1):109-15. PubMed ID: 26835711
[TBL] [Abstract][Full Text] [Related]
7. Detection of a 4-bp Insertion/deletion Polymorphism within the Promoter of EGLN2 Using Mismatch PCR-RFLP and Its Association with Susceptibility to Breast Cancer.
Hashemi M; Danesh H; Bizhani F; Sattarifard H; Hashemi SM; Bahari G
Asian Pac J Cancer Prev; 2018 Apr; 19(4):923-926. PubMed ID: 29693343
[TBL] [Abstract][Full Text] [Related]
8. Growth arrest-specific 5 (GAS5) insertion/deletion polymorphism and cancer susceptibility in Asian populations: A meta-analysis.
Gao G; Liu C; Li X; Guan X; Yang X; Qin P
Medicine (Baltimore); 2021 Oct; 100(41):e27415. PubMed ID: 34731115
[TBL] [Abstract][Full Text] [Related]
9. LncRNA GAS5 contributes to lymphatic metastasis in colorectal cancer.
Zheng Y; Song D; Xiao K; Yang C; Ding Y; Deng W; Tong S
Oncotarget; 2016 Dec; 7(50):83727-83734. PubMed ID: 27863421
[TBL] [Abstract][Full Text] [Related]
10. Impact of GAS5 genetic polymorphism on prostate cancer susceptibility and clinicopathologic characteristics.
Lin CY; Wang SS; Yang CK; Li JR; Chen CS; Hung SC; Chiu KY; Cheng CL; Ou YC; Yang SF
Int J Med Sci; 2019; 16(11):1424-1429. PubMed ID: 31673232
[TBL] [Abstract][Full Text] [Related]
11. Correlations of an Insertion/Deletion Polymorphism (rs10680577) in the RERT-lncRNA with the Susceptibility, Clinicopathological Features, and Prognosis of Lung Cancer.
Zhu J; Luo JZ; Li CB
Biochem Genet; 2019 Feb; 57(1):147-158. PubMed ID: 30073577
[TBL] [Abstract][Full Text] [Related]
12. Polymorphism in the promoter region of lncRNA GAS5 is functionally associated with the risk of gastric cancer.
Li Q; Ma G; Sun S; Xu Y; Wang B
Clin Res Hepatol Gastroenterol; 2018 Oct; 42(5):478-482. PubMed ID: 29602737
[TBL] [Abstract][Full Text] [Related]
13. LncRNA-GAS5 and its Promoter Region Polymorphism Associate with Helper Th17 Polarization and Predict Postoperative Pain and the Prognosis of the Patients with Hepatocellular Carcinoma Undergoing Hepatectomy.
Sha Z; Zhang P
Iran J Immunol; 2022 Dec; 19(4):349-357. PubMed ID: 36585876
[TBL] [Abstract][Full Text] [Related]
14. Association between indel polymorphism in the promoter region of lncRNA GAS5 and the risk of hepatocellular carcinoma.
Tao R; Hu S; Wang S; Zhou X; Zhang Q; Wang C; Zhao X; Zhou W; Zhang S; Li C; Zhao H; He Y; Zhu S; Xu J; Jiang Y; Li L; Gao Y
Carcinogenesis; 2015 Oct; 36(10):1136-43. PubMed ID: 26163879
[TBL] [Abstract][Full Text] [Related]
15. Effect of TP53 16-bp and β-TrCP 9-bp INS/DEL polymorphisms in relation to risk of breast cancer.
Eskandari-Nasab E; Hashemi M; Amininia S; Ebrahimi M; Rezaei M; Hashemi SM
Gene; 2015 Sep; 568(2):181-5. PubMed ID: 26003292
[TBL] [Abstract][Full Text] [Related]
16. Association of LncRNA-GAS5 gene polymorphisms and PBMC LncRNA-GAS5 level with risk of systemic lupus erythematosus in Chinese population.
Liu CH; Lu YL; Huang HT; Wang CF; Luo HC; Wei GJ; Lei M; Tan T; Wang Y; Huang YY; Wei YS; Lan Y
J Cell Mol Med; 2021 Apr; 25(7):3548-3559. PubMed ID: 33728802
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphism in HLA-G 3'UTR 14-bp ins/del and risk of cancer: a meta-analysis of case-control study.
Li T; Huang H; Liao D; Ling H; Su B; Cai M
Mol Genet Genomics; 2015 Aug; 290(4):1235-45. PubMed ID: 25573780
[TBL] [Abstract][Full Text] [Related]
18. Association of EGLN2 rs10680577 Polymorphism with the Risk and Clinicopathological Features of Patients with Prostate Cancer.
Rahimi N; Azizi M; Bahari G; Narouie B; Hashemi M
Asian Pac J Cancer Prev; 2020 May; 21(5):1221-1226. PubMed ID: 32458625
[TBL] [Abstract][Full Text] [Related]
19. A 40-bp insertion/deletion polymorphism of Murine Double Minute2 (MDM2) increased the risk of breast cancer in Zahedan, Southeast Iran.
Hashemi M; Omrani M; Eskandari-Nasab E; Hasani SS; Mashhadi MA; Taheri M
Iran Biomed J; 2014; 18(4):245-9. PubMed ID: 25326024
[TBL] [Abstract][Full Text] [Related]
20. A promoter variant of lncRNA GAS5 is functionally associated with the development of osteosarcoma.
Xu L; Xia C; Xue B; Sheng F; Xiong J; Wang S
J Bone Oncol; 2018 Sep; 12():23-26. PubMed ID: 30013899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
